ViruCure to attend the Armed Oncolytic Immunotherapies Summit Europe 2018, 26-28 June, Frankfurt, Germany

Meet with our CTO, Shay Tayeb, at the leading end-to-end meeting focused on the next generation of oncolytic virus therapies and discover more about ViruCure’s oncolytic virus technology, NADAV.